v3.26.1
Income Taxes (FY) (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes  
Schedule of deferred tax assets and liabilities
 
December 31,
(in thousands)
2025
2024
Deferred tax assets:
 
 
Net operating loss carryforwards
$105,425
$94,923
Research and development credits
55,020
50,842
Collaboration and license agreement
2,832
3,422
 
December 31,
(in thousands)
2025
2024
Capitalized research and development
46,041
59,803
Share-based compensation
4,329
5,863
Accrued expenses and other
4,581
1,404
Operating lease liabilities
6,520
7,560
Depreciation and amortization
1,048
461
Total gross deferred tax assets before valuation allowance
225,796
224,278
Valuation allowance
(222,752)
(219,833)
Net deferred tax assets
3,044
4,445
Deferred tax liabilities:
 
 
Right of use assets - operating leases
(3,044)
(4,445)
Total deferred tax liabilities
(3,044)
(4,445)
Net deferred taxes
$
$
Schedule of effective income tax rate reconciliation
 
Year ended December 31,
 
2025
2024
(in thousands)
Amount
Percent
Amount
Percent
US federal statutory tax rate
$(9,560)
21.0%
$(13,601)
21.0%
Federal:
 
 
 
 
Tax credits:
 
 
 
 
Research and development tax credits
(175)
0.4
(626)
1.0
Orphan drug tax credits
(4,003)
8.8
(4,896)
7.6
Changes in valuation allowances
12,334
(27.2)
17,422
(27.0)
Nontaxable or nondeductible items:
 
 
 
 
Share-based payment awards
241
(0.5)
459
(0.7)
Expiration of share-based payment awards
1,159
(2.5)
1,233
(1.9)
Other
4
0.0
9
0.0
State and local income taxes, net of federal income tax effect1
Effective tax rate
$
%
$
%
1
In 2025 and 2024, state and local income taxes in Pennsylvania and Philadelphia comprise the majority of the state and local income taxes, net of federal income tax effect category.
Schedule of net operating loss carryforwards
 
December 31,
(in thousands)
2025
2024
Federal
$398,039
$339,055
State
398,035
339,051
Local
277,828
218,844
Research tax credits
55,020
50,842